Cargando…
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis
S1.4 FUNGAL INFECTIONS IN ASIA, BRINGING IT OUT OF THE DARK, SEPTEMBER 21, 2022, 11:00 AM - 12:30 PM: BACKGROUND: Routine laboratory testing for cryptococcal meningitis currently consists of Cryptococcal antigen (CrAg) testing in blood and cerebrospinal fluid (CSF), CSF India ink, and CSF fungal c...
Autores principales: | Mbangiwa, Tshepiso, Sturny-Leclère, Aude, Lechiile, Kwana, Kajanga, Cheusisime, Chammard, Timothée Boyer, Lortholary, Olivier, Dromer, Francoise Dromer, Hoving, Jennifer C., Lawrence, David S., Mwandumba, Henry, Mosepele, Mosepele, Harrison, Tom, Jarvis, Joseph N, Alanio, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511514/ http://dx.doi.org/10.1093/mmy/myac072.S1.4d |
Ejemplares similares
-
Cryptococcus neoformans Host Adaptation: Toward Biological Evidence of Dormancy
por: Alanio, Alexandre, et al.
Publicado: (2015) -
Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome
por: Chammard, Timothée Boyer, et al.
Publicado: (2018) -
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation
por: Desnos-Ollivier, Marie, et al.
Publicado: (2015) -
Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
por: Dromer, Françoise, et al.
Publicado: (2008) -
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
por: Dromer, Françoise, et al.
Publicado: (2007)